All Sizes Covered, From Double Kill to Finishing Blow
As one of the top hospitals in the country, Huaxi Hospital's request to conduct clinical trials received the fastest response from Three Purities.
Previously, Three Purities conducted Phase I and II clinical trials in Kun City, while only conducting Phase III Clinical Trial in hospitals outside the province.
However, this time, due to a severe shortage of Artificial Blood Vessel and the supply falling short of demand, special approval was obtained from higher authorities to conduct Phase III clinical trial in key cities across the country ahead of schedule.
A few days later, the pharmaceutical representative arrived at Huaxi Hospital with a five-person research team.
In the spacious conference room, doctors from various departments gathered together, all looking curiously at the three refrigerators placed on the table.
With a "click," the refrigerator doors opened one by one, revealing neatly stacked Artificial Blood Vessel inside.
The research team leader looked around, smiled slightly, took one out of each box, and began to demonstrate them.
"These three boxes contain three sizes of Artificial Blood Vessel: large-diameter Artificial Blood Vessel (over 1 cm), medium-diameter Artificial Blood Vessel (6-8 mm), and Small-bore Artificial Blood Vessel under 6 mm)."
"As is well known, large-diameter Artificial Blood Vessel are suitable for arterial and major blood vessel replacement surgery, medium-diameter Artificial Blood Vessel are suitable for vascular bypass transplantation and the establishment of dialysis vascular access, but so far, no Small-bore Artificial Blood Vessel have been marketed."
"Three Purities's small-diameter Artificial Blood Vessel not only fills the domestic research and development gap, but is also the world's first clinically successful product, which will be widely used in peripheral vascular replacement, coronary artery bypass grafting, and arteriovenous AV Fistula surgery."
"Because large and medium-diameter Artificial Blood Vessel have been used in total aortic replacement surgery with very good treatment results, they can completely replace competing products. This is our clinical trial report."
"As for small-diameter blood vessels, we have optimized the materials used in their production, added an anticoagulant coating, and enhanced the strength and toughness of the blood vessels, which can provide a long-term antithrombotic effect."
"Animal Experiment show that the long-term effects are also very good. After a 16-week safety and efficacy trial, the replaced Artificial Blood Vessel were 100% unobstructed, and no thrombosis was observed after the operation. Many indicators are superior to imported products."
"We offer a wide range of models, from 1 mm to 36 mm, and we can even accept custom sizes, lengths, and specifications. We can handle all calibers. Just tell us your requirements, and we will do our best to meet them."
"I didn't bring many samples this time, only common models. Here are some of our technical parameters and clinical data. Please take a look."
After hearing the introduction, the doctors were immediately excited and applauded.
Applause rang out in the conference room.
As for the directors of departments such as Cardiothoracic Surgery Department, Hematology Department, and Urology Department, they all reached out and picked up the samples to examine them carefully.
As they watched, they whispered among themselves, exchanging their opinions and then passing them on to the doctors around them.
"It looks really good, and it feels great."
"This is a 3-millimeter-diameter blood vessel, right? It's really thin. This is the first time I've ever seen such a small blood vessel. It really looks exactly like a vein."
"Tsk tsk, there's even a 1-millimeter blood vessel, this is just showing off."
"Once it goes public, Maquet and Terumo will be in big trouble."
"Heh, if you dare to cut off supplies, you have to bear the consequences of customers finding alternatives."
"Haha, now I don't have to worry about shortages anymore. I can't wait to use it in surgery."
"I have a patient who needs coronary artery bypass surgery, but his blood vessels are in poor condition. I'm worried about the surgical options. Maybe I can switch him to this."
"Those patients in the Dialysis Room can be saved." Dr. Tang carefully held a 3-millimeter Artificial Blood Vessel, feeling the highly Bionic Hand that was almost indistinguishable from human blood vessels, and trembled with excitement.
Half an hour later, the sample was passed around among the people and then returned to the refrigerated box.
The head of Cardiothoracic Surgery stood up abruptly, unable to hide his excitement, and said, "I have several patients who need thoracic artery replacement surgery, and they are all waiting anxiously for the Artificial Blood Vessel to arrive. Now I can finally schedule their surgery."
The head of the Urology Department clenched his fist and excitedly pounded the table, saying, "There are many elderly people in the Dialysis Room. Some of them have been on dialysis for more than ten years. Their blood vessels are already broken and blocked. They need your Artificial Blood Vessel."
The head of the Hematology Department leaned back, urging in a good mood, "Oh, you two are in such a hurry, so what are we waiting for? Let's get started."
"Hahaha~" Everyone looked at each other and laughed, filling the conference room with a cheerful atmosphere.
After the meeting, the Three Purities team went to prepare for clinical trials, while the others returned to their respective departments.
As it grew dark, Dr. Tang followed behind, heading towards the Nephrology Department.
As he passed the Dialysis Center in the distance, he glanced at the entrance, and suddenly had an idea. He turned around and went inside.
The Dialysis Room remained as quiet as ever, like a silent battlefield, with each bed telling a story of the tenacity of life.
The nurses were constantly moving between the beds, monitoring the machines and observing the patients' conditions.
The dialysis patients were pale, swollen, and had dry, cracked lips. Some stared blankly at the Smallpox, while others closed their eyes to rest, silently waiting for time to pass.
When the kidneys lose their ability to drain urine, they can no longer urinate in small amounts frequently, and the amount of urine they need to produce every two days must be completely removed in a 4-hour dialysis session.
Each dehydration process means that blood from all over the body flows out into the dialysis machine, where the filter separates toxins and water before removing the remaining blood, which then returns to the body.
Every blood circulation, from the filling to the contraction and then the filling again of blood vessels, is a severe test for the blood vessels and the heart.
The more water you drink, the more likely your blood pressure will fluctuate wildly, and the greater the likelihood of experiencing symptoms such as weakness, Hypotension, muscle cramps, and heart failure after dialysis.
The long-term imbalance of water and electrolytes in the body, as well as the accumulation of various toxins such as creatinine and uremia, all make dialysis patients more prone to thirst.
Being thirsty but having to restrict their water intake means they forever lose the joy of drinking water.
Everyone must begin to live a life of careful budgeting for the rest of their lives. The daily water intake should not exceed 3%, and the two-day intake should not exceed 5%. An adult male should not drink more than 3 kilograms of water in two days.
3 kilograms of water is roughly equivalent to 6 bottles of common mineral water, including the water consumed during breakfast, lunch, and dinner.
Rice, vegetables, Apple all contain water, and you also need to drink water when taking medicine. Apart from these, you can probably only drink one bottle of mineral water a day, and you can easily exceed the recommended amount if you're not careful.
As a result, dialysis patients are perpetually thirsty, and their entire remaining lives are like those of travelers who have lost their water bags, wandering in a vast desert, thirsty but unable to drink water.
This feeling doesn't drive people crazy or manic like when they have a drug addiction attack. Instead, it's more like a subtle and continuous torment of the mind, like slowly and persistently cutting flesh with a soft knife.
What's even more cruel is that Hemodialysis requires going to the hospital every one or two days and spending four hours lying motionless in bed, which greatly restricts freedom.
As a result, most patients are no longer able to attend school or work normally, becoming marginalized members of society at a young age, turning from the hope and pillar of their families into burdens and hindrances.
Dialysis is like an invisible rope that binds patients, leaving them with neither health, freedom, nor hope.
Dr. Tang looked at each hospital bed, his gaze falling on the familiar yet numb faces, and his initially cheerful mood instantly turned somber.
It took him a while to recover. He walked to the patients, raised his hand and clapped three times, then called out loudly.
"Hello everyone, I'm Old Tang from the Nephrology Department. Many of you are my patients. Today I have some good news to share with you."
The patients' eyes immediately focused on him, each one filled with curiosity and anticipation.
"Do you remember what I said? I once said, don't be discouraged, embrace reality, and always have hope for the future."
"Society is changing rapidly, and technology is advancing every day. As long as we continue to develop, miracles will happen to you sooner or later."
"Of course, miracles are not built in a day or achieved overnight, but happen slowly, from quantitative change to qualitative change."
"The same is true in medicine. The last good news I brought you was that there was a drug to treat Chronic Nephritis. Now, less than a year later, I have another good news for you."
"Sanqing Group has successfully developed Small-bore Artificial Blood Vessel that can replace your own blood vessels to treat AV Fistula. The Phase III Clinical Trial is currently underway at our hospital."
"Those of you who are older, frequently experience blood clots, or have already used Artificial Blood Vessel for AV Fistula dysfunction, can go to the clinical building next to the Inpatient Department to apply for clinical trials and use their Artificial Blood Vessel."
"Don't be afraid of the trouble. The trial is free and won't cost you a penny, but it will make your blood vessels clearer and less prone to blood clots."
Dr. Tang became more and more excited as he spoke, "Believe me, everyone should apply for clinical trials tomorrow."
"These are the gradual changes brought about by technology. I hope that the next good news I bring you will be the miracle that Uremia can be completely cured."
The patients looked at each other, initially stunned, but quickly realized what was happening and became overjoyed.
Unable to sit up, they could only lie on their beds, asking questions all at once.
Dr. Tang smiled and patiently answered his questions.
The patients' fatigue vanished, and they seemed to have a temporary, miraculous surge of strength within them. Their voices grew louder, and their faces regained their radiance.
The noise inside attracted the attention of the people waiting for dialysis outside, and many people stood at the door, peering inside.
Many of the people there recognized Dr. Tang immediately and rushed to his side.
Dr. Tang smiled broadly, waved to them, and spoke in a strong voice.
"I have good news for you."
******
Huaxi Hospital is not the only hospital to start Phase III Clinical Trial ahead of schedule.
Well-known Grade A Tertiary Hospitals in first- and second-tier cities such as Yangcheng, Capital City, Sea City, and Shacheng City have also taken action.
They had previously had in-depth clinical collaborations with Three Purities, and Three Purities would naturally be eager to cooperate as long as the higher authorities allowed it.
Soon, news of Three Purities's successful development of Small-bore Artificial Blood Vessel, solving an international problem and filling an industrial gap, spread like wildfire and became ubiquitous.
However, unlike the large-diameter Artificial Blood Vessel that shocked netizens across the country, this time it shocked industry insiders.
Domestic medical device manufacturers were very excited, and they were all grinning from ear to ear.
This indicates a new direction for the development of Artificial Blood Vessel. Biomaterials are undoubtedly more suitable and have a brighter future than the old polyester materials.
In particular, the upstream polyester material has long been monopolized by foreign manufacturers, making it difficult for domestic manufacturers to break through patent blockades and independently develop new materials.
Now, Three Purities has pointed them in the direction of biological protein materials, proving its feasibility.
They could simply follow suit, work towards this goal, and develop new materials.
The effects may not be as outstanding as Three Purities, but by taking a cost-effective approach and creating tiered pricing, it can still be very profitable.
They can even become OEM manufacturers or suppliers for Three Purities brand of pharmaceuticals). As long as they are in this industry chain, they can make money to some extent.
After all, the demand for 40,000 Artificial Blood Vessel per year will only increase in the future. Three Purities certainly cannot handle it all by itself. If it produces them all, it will have to share the profits with its many competitors.
Previously, these tens of thousands of Artificial Blood Vessel were all imported, and they couldn't even get a sip of soup.
Now that Artificial Blood Vessel have broken the monopoly and are completely domestically produced, it means that everyone can now sit down and enjoy the meal.
They'll at least get a small slice of this freshly baked cake, which is much better than before when they could only watch helplessly.
In stark contrast to the jubilation of domestic manufacturers, Terumo and Maquet were utterly disheartened.
Faced with this situation, they were all at a loss and had no way to deal with it.
One new factory has been open for 5 years but has not yet restored its production capacity, while another was directly defeated by a strong force due to quality problems.
Both companies brought this upon themselves; their long-term advantage made them complacent, leading to various mistakes and ultimately handing over the market to others. They have no one to blame but themselves.
What annoyed them even more was that the flagship products of both companies were large and medium-diameter Artificial Blood Vessel.
They couldn't handle small-diameter blood vessels either, and could only watch the news about Three Purities with gritted teeth and impotent rage.
Three Purities's development of large-diameter and medium-diameter Artificial Blood Vessel has already dealt a double blow to these two companies.
Once a small-diameter blood vessel of less than 6 millimeters is found, it becomes an instant kill.
Everyone in the industry understands that once Three Purities's Artificial Blood Vessel hit the market, the entire industry will be completely reshuffled, resulting in a bloodbath.
Imported blood vessels in the domestic market are completely finished; it's only a matter of time before they are replaced by Three Purities.
As for the overseas market, it may initially be a three-way competition. Gradually, as Three Purities's small-diameter blood vessels gain momentum, and domestic sales drive the overseas market, Three Purities will complete its comeback and ascend to the throne of the Artificial Blood Vessel enterprise within just a few years.
"In a few years, when Three Purities also occupies more than 50% of the market in multiple fields and achieves a monopoly, what a beautiful and spectacular sight that will be."
As Wei Kang sat in his office, imagining this scene, the corners of his mouth couldn't help but turn up in a smile.